General Information of Drug (ID: DR5304)
Drug Name
Trientine
Synonyms
Trientine HCl; 21121-06-2; triethylenetetramine HCl; SMR000058543; AC1NUQ0M; MLS000069683; SCHEMBL205201; CHEMBL1200783; CTK0I9735; DTXSID80419994; XPVOJYDIBHYVFL-UHFFFAOYSA-N; Pharmakon1600-01505675; NSC759164; NSC158271; AKOS027276425; NSC-158271; NSC-759164; 1, N,N'-bis(2-aminoethyl)-, tetrahydrochloride; 1,2-Ethanediamine, N,N'-bis(2-aminoethyl)-, hydrochloride; N'-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine hydrochloride
Indication Inborn error of metabolism [ICD11: 5C50-5C59] Approved [1]
Structure
3D MOL 2D MOL
Pharmaceutical Properties Molecular Weight 146.23 Topological Polar Surface Area 76.1
Heavy Atom Count 10 Rotatable Bond Count 7
Hydrogen Bond Donor Count 4 Hydrogen Bond Acceptor Count 4
Cross-matching ID
PubChem CID
5565
ChEBI ID
CHEBI:39501
CAS Number
112-24-3
TTD Drug ID
D09VAZ
Formula
C6H18N4
Canonical SMILES
C(CNCCNCCN)N
InChI
InChI=1S/C6H18N4/c7-1-3-9-5-6-10-4-2-8/h9-10H,1-8H2
InChIKey
VILCJCGEZXAXTO-UHFFFAOYSA-N
The Metabolic Roadmap of This Drug
The Full List of Drug Metabolites (DM) of This Drug
DM Name DM ID PubChem ID Reaction DM Level REF
N1-acetyltriethylenetetramine(MAT) DM019927 N. A. Conjugation - Acetylation 1 [2] , [3]
Nicotinic acid DM003548
938
Conjugation - Acetylation 1 [2] , [3]
The Full List of Metabolic Reaction (MR) of This Drug
MR ID Reactant Product MR Type DME REF
MR012774 Trientine N1-acetyltriethylenetetramine(MAT) Conjugation - Acetylation SAT1 [2], [3]
MR012775 Trientine NA Conjugation - Acetylation SAT1 [2], [3]
References
1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2 Triethylenetetramine pharmacology and its clinical applications
3 Comparison of the Pharmacokinetic Profiles of Trientine Tetrahydrochloride and Trientine Dihydrochloride in Healthy Subjects

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.